Tucker Asset Management’s Amedisys AMED Stock Holding History

Tucker Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26	Closed	-$4.48K	–	640
2022 Q1	$4.48K	Hold	26	–	–	﹤0.01%	335
2021 Q4	$4.27K	Buy	+26	New	+$4.18K	﹤0.01%	320

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Tucker Asset Management's AMED Position: Q2 2022 in Review

Tucker Asset Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 26 shares — an estimated $4.48K sold.

Tucker Asset Management first reported a position in AMED in Q4 2021 and held it in 2 quarters. The position peaked at $4.48K in Q1 2022. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

Tucker Asset Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
Tucker Asset Management sold 26 Amedisys shares in Q2 2022, an estimated $4.48K.
Tucker Asset Management first reported a position in Amedisys in Q4 2021 and held it in 2 quarters.
Tucker Asset Management's Amedisys position peaked at $4.48K in Q1 2022.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Tucker Asset Management's 13F filing for Q2 2022, filed 11 May 2023.